William Hilson
Chairman at Diamond Therapeutics, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Judy Blumstock | F | - |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | 6 years |
Richard Boadway | M | 73 |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | - |
Barbara Linarducci | F | - |
Silvermine Arts Center
| - |
Mark Carta | M | - |
Silvermine Arts Center
| - |
Jon Puzzuoli | M | - |
Silvermine Arts Center
| - |
Michael Maresca | M | - |
Silvermine Arts Center
| - |
Roger Mudre | M | - |
Silvermine Arts Center
| - |
Carlos Garrido | M | - |
Silvermine Arts Center
| - |
Svetlin Tchakarov | M | - |
Silvermine Arts Center
| - |
Claire Cohen | F | - |
Silvermine Arts Center
| - |
Hui Tang | F | 64 |
Silvermine Arts Center
| - |
James McCutcheon | M | 61 |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | - |
Gianni Mucci | M | - |
Cronos Growing Co., Inc.
Cronos Growing Co., Inc. Real Estate DevelopmentFinance Cronos Growing Co., Inc. provides cannabis products. It specializes in cannabis farming, cannabis cultivation and extraction products. The company is headquartered in Toronto, Canada. | - |
Umberto Mucci | M | - |
Cronos Growing Co., Inc.
Cronos Growing Co., Inc. Real Estate DevelopmentFinance Cronos Growing Co., Inc. provides cannabis products. It specializes in cannabis farming, cannabis cultivation and extraction products. The company is headquartered in Toronto, Canada. | - |
Peter Pekos | M | - |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | - |
Michael Gorenstein | M | 37 |
Cronos Growing Co., Inc.
Cronos Growing Co., Inc. Real Estate DevelopmentFinance Cronos Growing Co., Inc. provides cannabis products. It specializes in cannabis farming, cannabis cultivation and extraction products. The company is headquartered in Toronto, Canada. | - |
Michelle Loh | F | - |
Silvermine Arts Center
| - |
Rose-Marie Fox | F | 72 |
Silvermine Arts Center
| - |
Dmitri Wright | M | - |
Silvermine Arts Center
| - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 12 | 63.16% |
Canada | 7 | 36.84% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- William Hilson
- Personal Network